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Editorial on the Research Topic
Immunoparasitology: A Unique Interplay Between Host and Pathogen
This Research Topic, “Immunoparasitology: A unique interplay between host and pathogen,” was
intended to emphasize broadly the latest advances in immunoparasitology and has been concluded
with more than 30 high quality papers encompassing aspects of parasite biology, host-parasite
responses and interactions, and up-to-date control measures. Such an accomplishment is
unattainable without the enthusiastic involvement of all contributing authors and participating
reviewers, and the day-to-day assistance from the staff of Frontiers in Immunology editorial office.
Approximately one third of the articles in this collection are reviews and the rest are original
research papers, covering multiple parasitic species and their hosts. As expected, two thirds of
the papers are focused on protozoan parasites, 50% of which use Toxoplasma gondii as a model
pathogen. The next-most covered group is parasitic helminths with eight papers. At the time this
Editorial was submitted for publication, this Research Topic achieved well over 75,000 online views,
with average views per article of>2,000 since publication.
The most viewed article covers the popular and important subject of co-infection (Mabbott).
The author emphasizes the fact that co-infection is a common occurrence in the field, where
malarial parasites, soil-transmitted helminths, bacteria and viruses, are the causes for chronic
infections in a large proportion of the population. Ample examples of co-infection are described,
where existing infections by parasites can have a dramatic influence on host susceptibility and/or
disease pathogenesis. The impact of co-infection on disease diagnosis, vaccine development, and
host resistance, clearly warrants further investigation. The findings of Djokic et al. demonstrate
specifically how co-infection by Babesia microti and Borrelia burgdorferi, both tick-borne
pathogens, influences age-dependent immune responses and disease outcomes. Additional review
articles cover protozoa and helminths, representing up-to-date advances in research. Maurya et al.
present an excellent review on the functions of leptin in infectious diseases. Leptin, primarily
secreted by adipose tissue, is important in resistance to diseases as it is emerging as a key regulator
in both immunity and nutrition.
While malaria and trypanosomiasis are not extensively covered in this issue, in terms of
original research, research progress for these two diseases is nonetheless summarized by several
in-depth reviews. Lee et al. give an expert account of recent advances in the complex cytoadhesive
interactions between Plasmodium falciparum-infected erythrocytes and other host cells, providing
insight into how such cytoadherence may contribute to malaria pathogenesis. In malaria, B
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cell-mediated, parasite-specific, antibody-dependent protection
may depend on, and be achieved by, appropriate activation in the
lymph nodes and optimal interactions among antigen-specific
and antibody-secreting B cells with T helper cells and cytokines.
This process is described in depth in a review article written by
Silveira et al..
Several major species of trypanosomes are the pathogenic
agents of trypanosomiasis worldwide, profoundly affecting
the well-being and immunocompetency of both humans and
animals. To date, there is no vaccine against trypanosomiasis,
although the parasite can elicit strong immune responses in
the host. The difficulty in developing protective vaccines stems
from the ability of parasites to evolve and evade host immune
surveillance by genetic exchange among the parasites, acquisition
of resistant genotypes in the insect vector, and plasticity in
adaptation in new environments (Radwanska et al.). One of
the approaches to understanding differential host responses is
by investigating routes of transmission. Berreto de Albuquerque
et al. summarize their recent findings and those of others
in comparing host responses and disease outcomes following
Trypanosoma cruzi infection through oral or gastrointestinal
routes. In Latin American countries, oral transmission of
resultant Chagas disease is predominant. In animal models,
the oral route of infection can give rise to higher rates of
mortality and morbidity when compared to vector-mediated
transmission. These authors indicate that oral transmission, in
fact, consists of intraoral cavity and intragastric transmissions,
with increased parasitemia and mortality through the intraoral
cavity route (Berreto de Albuquerque et al.). T. cruzi appears
to enhance its replication in macrophages by exploiting the
cell’s Wnt signaling system based upon the ability of Wnt/β-
Catenin signaling inhibition in vitro and in vivo to restrict T.
cruzi replication, thereby promoting host resistance (Volpini
et al.). Similarly, Leishmania amazonensis, a close relative of the
trypanosome, also promotes its own infectivity using a host cell
protein, CD100, through a macrophage surface receptor, CD72
(Galuppo et al.).Histomonasmeleagridis is a flagellated protozoan
parasite, causing histomonosis in turkeys and chickens, with the
latter being more resistant to infection (Mitra et al.). Recent
studies by Kidane et al. show that, unlike turkeys, resistance
in chickens relies on the presence of higher percentage of
interferon-gamma (IFN-γ) positive cells early in infection.
Infections caused by parasitic protozoa are very common in
humans and animals, and the clinical symptomsmay be transient
or asymptomatic; but infected, apparently healthy individuals
may remain infected throughout life, e.g., toxoplasmosis. Many
years of research on T. gondii as a model zoonotic pathogen
has advanced the field tremendously. Important discoveries
continue to be made using this model and provide the
basis for translational research. Indeed, findings of articles
in this Research Topic show that Toxoplasma infection in
the cat, the definitive host for T. gondii, elicits multi-
tissue transcriptional changes mostly associated with immune
functions (Cong et al.). Findings by Liu et al. demonstrate that
galectin-3 and galectin-9 differentially regulate the expression of
microglial M1/M2macrophagemarkers and T helper 1/2 (Th1/2)
cytokines in the brain of genetically susceptible (C57Bl/6)
or resistant (Balb/c) mice, following peroral infection with
T. gondii. Further, acute infection with T. gondii induces
M1 polarization in the mouse brain, while chronic infection
with the same strain inhibits the harmful Th1-associated
inflammatory responses while M1 phenotype is maintained,
indicating the complexity of the immune initiation stage upon
infection (Hwang et al.). Admittedly, description of macrophage
phenotypes and associated functions is rapidly expanding,
thereby the intricate role of macrophage lineages in response to
T. gondii infection warrants extensive investigation.
In North America and Europe, the strains of types I, II, and
III T. gondii predominate, while in China, type Chinese 1 for T.
gondii is prevalent. The type Chinese 1 is unique in that it carries
a type II GRA15 protein (GRA15II) and a type I ROP16 protein
(ROP16I), and known to polarize the host macrophages toward
both M1 andM2 phenotypes at the early stage of infection. Using
the type Chinese 1 strain deficient of ROP16I/III, WH31rop16,
created with CRISPR/Cas9 technology, it is evident that pregnant
mice infected withWH31rop16 have elevated Th1, but repressed
Th2 and Treg responses, leading to pregnancy failure (Wang
et al.). This suggests that disturbance of host immunotolerance
during pregnancy by T. gondii or its sister parasite Neospora
caninum can contribute to pregnancy failure.
T. gondii ROP18 is an essential virulence factor but its
interaction with host targets has not been studied extensively.
In an effort to identify ROP18 binding partners in human
cells, Xia et al. use a high-throughput bimolecular fluorescence
complementation (BiFC) approach to reveal numerous human
protein partners for the type I and II strain ROP18, most of
which are related to immune responses and apoptosis. Future
studies will be needed to analyze the physiological significance
of such host-parasite protein-based interactions. Further, IFN-
γ-induced degradation of tryptophan by indoleamine 2, 3-
dioxygenase (IDO) is a crucial anti-Toxoplasma mechanism.
Recent investigations by Bando et al. show that, of the two
IDO isoforms in humans, IDO1 is required for IFN-γ-induced
immunity against toxoplasmosis.
Toxoplasmosis is one of the leading foodborne causes of
deaths. The disease can be transmitted by oocysts in cat feces
and contaminated undercooked meats. While there is a need
for an effective vaccine against toxoplasmosis in humans and
animals, most vaccines studied thus far are low in protective
efficacy and remain at the experimental stage. Toxoplasma DNA
vaccines containing a single antigen (TgDOC2) and multiple
antigens (TgPF, TgROP18, TgROP18, TgMIC6 and TgCDPK3)
are reported (Zhang, Elsheikha et al.; Zhang, Hou et al.).
Both vaccines achieved considerable protection against challenge
in the mouse model of infection. Development of vaccines,
particularly efficacious and cost-effective subunit vaccines, is
challenging for all parasites. Thus, far, the best protection is still
achieved by live attenuated vaccines. Research by Xia et al. reveals
that a T. gondii mutant (1ldh) lacking lactate dehydrogenases
1 and 2 propagates in vitro, but not in vivo. Mice vaccinated
with this mutant are protected from lethal challenges with
wild-type strains of T. gondii (Xia et al.). It is very promising
that such mutants can provide protection but are unable to
replicate in animals, as this may lead to development of live
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attenuated vaccines and identification of candidate antigens for
subunit vaccines. Translational research will be required to assess
protective efficacy in target species.
Avian coccidiosis caused by Eimeria spp. results in production
losses to the poultry industry. Kim, Chaudhari et al. review
the literature encompassing many years of research on the
complex host responses to this infection that include typical
Th1 inflammatory responses and those mediated by Treg cells,
highlighting the importance of Th17T cell subsets in host
resistance/susceptibility to coccidiosis. In addition, studies by
the same group show that the dietary indoles, ligands for the
aryl hydrocarbon receptor, upregulate Treg responses while
downregulate Th17 responses, leading to reduced host intestinal
lesions caused by coccidiosis (Kim, Lillehoj et al.). This suggests
that effective dietary treatments can alleviate coccidiosis-elicited
pathogenesis and/or reduce or prevent subsequent opportunistic
infections (Kim, Lillehoj et al.).
There are numerous important animal and human
pathogens in the phylum Apicomplexa, such as Plasmodium
spp., Toxoplasma gondii, Eimeria spp., Babesia spp., and
Cryptosporidium spp. Natural killer (NK) cells are potent first
line effector cells in control of apicomplexan infections by
producing IL-12-dependent IFN-γ and direct killing of the
parasites and infected cells (Ivanova et al.). However, functions
attributed to NK cells may be functions of one of the innate
lymphoid cell (ILCs) lineages based on extensive and vigorous
research performed since the discovery of ILCs; as such,
intensive research is justified to understand the functions of
these emerging and important ILCs in the interaction between
Apicomplexa parasites and their hosts (Ivanova et al.).
Parasitic helminths are multicellular, eukaryotic, invertebrates
of medical and veterinary importance. In the past decades,
animal and human parasitic helminth control has relied almost
entirely on anthelmintic drugs. However, drug-resistant parasites
are emerging, illustrating the need for intense research on
the parasitic worms and development of alternative control
measures. In addition, prior or existing exposure to, and
infection by, helminths can result in polarized immune responses
in the host. Such a preexisting immunologic background
can unavoidably affect the host immune responses and
outcome of infections caused by bacterial, viral or fungal
pathogens (Mabbott). Eight articles in this issue, most of
which describe original research, emphasize helminths infecting
humans and animals. The review article in this Research Topic is
focused on helminth-mediated immunoregulation through host
pattern recognition receptor (PRR)-dependent and -independent
mechanisms (Zakeri et al.), involving host-parasite interactions
via parasitic excretory/secretory products and extracellular
vesicles. The outcome of such a cross-regulation is two-fold, in
general. On the one hand, the worms have evolved to acquire
the ability to manipulate the host immune responses in favor
of their own survival and parasitism. On the other hand, the
host requires exposure to helminth infections for establishing
a bystander immunity essential for downregulating deleterious
host responses due to allergies and autoimmune diseases. Indeed,
the results of recent studies by Ebner et al. indicate that, using
a cell line in combination with the infective Ascaris suum
larvae in vitro and analysis by dual-species RNA-Seq, worm
exposure elevates host metabolic activities and suppresses some
of the chemotactic genes, but does not affect overall immune
responsive genes or immune signaling pathways. However, upon
contact with the host cell, Ascaris larval genes responsible for
motor function development and invasion are upregulated, an
example of parasitic evasion and promotion of self-development,
migration and survival.
Trichinella spiralis, an important food-borne pathogen,
attenuates collagen-induced arthritis through programmed death
1 (PD1) by downregulating Th1/Th17 responses, an instance
of a therapeutic effect exerted by helminth infections (Cheng
et al.). Results of the recent studies by these investigators
illustrate that infection by T. spiralis elevates PD1 in CD4T
cells, and mice infected with the parasite have reduced pathology
of collagen-induced arthritis. Moreover, the infection-induced
therapeutic effect can be abolished by anti-PD1 antibodies.
Lack of such a therapeutic effect is shown in PD1-deficient
mice, further demonstrating the importance of PD1 (Cheng
et al.). Using a bioinformatics systems approach, Homan et al.
further demonstrate the importance of co-infection by epitope
networking. In this study, predicted T cell epitopes of multiple
helminth species and the associated host responses are analyzed
for their ability to bind with MHC molecules, as well as for
the presence of T cell-exposed motifs, which are comprised of
amino acids in a peptide bound to MHC molecules that engage
the T cell receptor. Interestingly, T cell-exposed motifs identified
in the study are shared among the helminth species and with
the taxonomically unrelated pathogens commonly seen in co-
infections. The results indicate that a systems approach must
be taken when investigating an infection against a backdrop
of co-infection and the potential presence of preexisting
immune response bias. In the highly complex process of host-
gastrointestinal (GI) parasite interactions, the interrelationship
between the parasite and the host GI microbiota should also
be considered. Heligmosomoides polygyrus, a nematode that
infects the small intestine of mice, produces excretory/secretory
products with antimicrobial activities (Rausch et al.). Using
the germ-free rodent model, research conducted by Rausch
et al. shows that the parasite may sense and modulate enteric
microbiota, in their favor, by controlled release of nematode-
derived antimicrobial excretory/secretory products.
Anti-worm vaccines are considered an important alternative
to anthelmintics in the face of rapid emergence of drug
resistance in the worm; thus, it is crucial to identify protective
vaccine candidates in parasitic worms of interest. The
Haemonchus contortus serine/threonine-protein phosphatase,
an excretory/secretory protein, is identified and characterized
for its potential to be a vaccine candidate, based on the protein’s
ability to modulate cytokine production, immune cell migration,
and apoptosis, and to downregulate cell proliferation and
MHC protein expression (Ehsan et al.). Immunodominant
structural proteins and a wide range of moonlighting proteins
are identified using combined 2-dimensional electrophoresis and
LS-MS/MS in worm extract as well as surface preparations from
the adult tapeworm Hymenolepis diminuta (Mlocicki et al.).
Some of the proteins may be excellent vaccine candidates. It
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has been known that granulocytes play a key role in bridging
the innate and acquired immunities and mediating clearance of
helminth infections. The study by Rajamanickam et al. illustrates
that Strongyloides stercoralis infection promotes the level of
eosinophil, neutrophil, and mast cell granule proteins present in
peripheral blood, while anthelmintic drug treatment suppresses
them, indicating a direct involvement of activated granulocytes
during helminth infection.
Taken together, this Editorial gives a brief overview of the
findings presented by all articles in this Research Topic, and
we hope that these articles provide readers a cross-sectional
view of status of current research on some of the parasites of
medical and veterinary importance. This collection of articles
provides valuable and timely insights into the need for, and
recent developments in, parasite research, the mechanisms
underlying infection and pathogenesis, and potential therapeutic
and prophylactic interventions. Humans and animals in their
life times are confronted with constant threat of infections
by, or exposure to, several types of parasites, in addition to a
whole battery of other pathogens. Parasitic infections may result
in protective immunity for life, biased/compromised immune
functions, and/or loss of productivity. As stated earlier, the
underlying conditions, such as biased immune status by previous
parasitic infection or exposure, can be determining factors
influencing potential immunities against pathogens which are
irrelevant to those of prior exposure. In the laboratory setting,
experiments must be designed in such a way as to yield definitive
results. However, in the field, we must appreciate that co-
infection of individuals is often inevitable. Again, this Research
Topic is focused on host-parasite interactions, and those who
contributed to this special issue have addressed the importance
and significantly advanced the research in each field. We eagerly
look forward to advances in parasitology research in the coming
years, and to a greater understanding of the interplay between
parasites, the host, and other infections in particular.
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